Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.
"There is no correlation between the extent and activity of skin lesions and the presence, severity, and activity of extracutaneous manifestations," according to pediatric dermatologist, Elena Pope, MD.
A novel treatment algorithm for psoriatic arthritis (PsA) is being developed to provide more precise biologic choices.
Deep-learning programming can be trained to distinguish inflammatory joint diseases with reasonable accuracy.
New studies assess patients with various immune-mediated inflammatory diseases to determine the risks and benefits of pausing methotrexate after the COVID-19 vaccine.